“Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care”, Bleeding Thromb Vascul Biol, vol. 1, no. 1, Apr. 2022, doi: 10.4081/btvb.2022.9.